[go: up one dir, main page]

AU2009901743A0 - A Novel Formulation of Metaxalone - Google Patents

A Novel Formulation of Metaxalone

Info

Publication number
AU2009901743A0
AU2009901743A0 AU2009901743A AU2009901743A AU2009901743A0 AU 2009901743 A0 AU2009901743 A0 AU 2009901743A0 AU 2009901743 A AU2009901743 A AU 2009901743A AU 2009901743 A AU2009901743 A AU 2009901743A AU 2009901743 A0 AU2009901743 A0 AU 2009901743A0
Authority
AU
Australia
Prior art keywords
metaxalone
novel formulation
formulation
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2009901743A
Inventor
H. William Bosch
Aaron Dodd
Felix Meiser
Marck Norret
Adrian Russell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Iceutica Pty Ltd
Original Assignee
Iceutica Pty Ltd
Filing date
Publication date
Application filed by Iceutica Pty Ltd filed Critical Iceutica Pty Ltd
Publication of AU2009901743A0 publication Critical patent/AU2009901743A0/en
Priority to JP2012506286A priority Critical patent/JP6116243B2/en
Priority to CA2759113A priority patent/CA2759113C/en
Priority to NZ595903A priority patent/NZ595903A/en
Priority to BRPI1014278A priority patent/BRPI1014278B8/en
Priority to CN201410145550.2A priority patent/CN104000785B/en
Priority to NZ710322A priority patent/NZ710322A/en
Priority to US13/266,115 priority patent/US20120263760A1/en
Priority to EP10766517.6A priority patent/EP2421530B1/en
Priority to MX2011011233A priority patent/MX360019B/en
Priority to PCT/AU2010/000468 priority patent/WO2010121324A1/en
Priority to CN201080017990XA priority patent/CN102438621A/en
Priority to AU2010239082A priority patent/AU2010239082B2/en
Priority to IL215864A priority patent/IL215864B/en
Priority to ZA2011/08644A priority patent/ZA201108644B/en
Priority to US14/250,190 priority patent/US20140302127A1/en
Priority to AU2014227473A priority patent/AU2014227473B2/en
Priority to JP2015101975A priority patent/JP6324925B2/en
Priority to US14/977,314 priority patent/US20160108009A1/en
Priority to AU2016216723A priority patent/AU2016216723B2/en
Priority to US15/482,598 priority patent/US20180009769A1/en
Priority to JP2017169071A priority patent/JP2018021058A/en
Priority to IL256841A priority patent/IL256841B/en
Priority to US15/970,651 priority patent/US20180251433A1/en
Priority to US16/847,628 priority patent/US20200308123A1/en
Priority to US17/329,034 priority patent/US20210403442A1/en
Abandoned legal-status Critical Current

Links

AU2009901743A 2009-04-24 2009-04-24 A Novel Formulation of Metaxalone Abandoned AU2009901743A0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
AU2010239082A AU2010239082B2 (en) 2009-04-24 2010-04-23 A novel formulation of metaxalone
CN201410145550.2A CN104000785B (en) 2009-04-24 2010-04-23 Novel dosage forms of metaxalone
CA2759113A CA2759113C (en) 2009-04-24 2010-04-23 A novel formulation of metaxalone
NZ595903A NZ595903A (en) 2009-04-24 2010-04-23 A novel formulation of metaxalone
BRPI1014278A BRPI1014278B8 (en) 2009-04-24 2010-04-23 method for producing a dosage form comprising metaxolone, dosage form, pharmaceutical composition comprising said dosage form and use thereof
JP2012506286A JP6116243B2 (en) 2009-04-24 2010-04-23 New formulation of Metaxalone
NZ710322A NZ710322A (en) 2009-04-24 2010-04-23 A novel formulation of metaxalone
US13/266,115 US20120263760A1 (en) 2009-04-24 2010-04-23 Novel formulation of metaxalone
EP10766517.6A EP2421530B1 (en) 2009-04-24 2010-04-23 Formulation of metaxalone
MX2011011233A MX360019B (en) 2009-04-24 2010-04-23 A novel formulation of metaxalone.
PCT/AU2010/000468 WO2010121324A1 (en) 2009-04-24 2010-04-23 A novel formulation of metaxalone
CN201080017990XA CN102438621A (en) 2009-04-24 2010-04-23 New formulations of metaxalone
IL215864A IL215864B (en) 2009-04-24 2011-10-23 Formulation of metaxalone
ZA2011/08644A ZA201108644B (en) 2009-04-24 2011-11-24 A novel formulation of metaxalone
US14/250,190 US20140302127A1 (en) 2009-04-24 2014-04-10 Novel formulation of metaxalone
AU2014227473A AU2014227473B2 (en) 2009-04-24 2014-09-17 A Novel Formulation of Metaxalone
JP2015101975A JP6324925B2 (en) 2009-04-24 2015-05-19 New formulation of Metaxalone
US14/977,314 US20160108009A1 (en) 2009-04-24 2015-12-21 Novel formulation of metaxalone
AU2016216723A AU2016216723B2 (en) 2009-04-24 2016-08-19 A Novel Formulation of Metaxalone
US15/482,598 US20180009769A1 (en) 2009-04-24 2017-04-07 Novel formulation of metaxalone
JP2017169071A JP2018021058A (en) 2009-04-24 2017-09-04 Novel formulation of metaxalone
IL256841A IL256841B (en) 2009-04-24 2018-01-10 A novel formulation of metaxalone
US15/970,651 US20180251433A1 (en) 2009-04-24 2018-05-03 Novel formulation of metaxalone
US16/847,628 US20200308123A1 (en) 2009-04-24 2020-04-13 Novel formulation of metaxalone
US17/329,034 US20210403442A1 (en) 2009-04-24 2021-05-24 Novel formulation of metaxalone

Publications (1)

Publication Number Publication Date
AU2009901743A0 true AU2009901743A0 (en) 2009-05-14

Family

ID=

Similar Documents

Publication Publication Date Title
IL215864A0 (en) A novel formulation of metaxalone
AP3774A (en) A novel formulation of diclofenac
AP3628A (en) A novel formulation of indomethacin
AP3659A (en) A novel formulation of meloxicam
EP2599427A4 (en) Rigid scope
WO2010114629A9 (en) Formulation
EP2512242B8 (en) Novel compounds
AU2009901743A0 (en) A Novel Formulation of Metaxalone
IL256841B (en) A novel formulation of metaxalone
AU2009901742A0 (en) A Novel Formulation of Meloxicam
AU2009901748A0 (en) A Novel Formulation of Diclofenac
IL257014A (en) A novel formulation of meloxicam
AU2009901746A0 (en) A Novel Formulation of Naproxen
AU2009901745A0 (en) A Novel Formulation of Indomethacin
HK1162341A (en) Novel use of fibrates
AU2009905979A0 (en) Novel glyphosate formulation
AU2014201356B2 (en) Combined measles-malaria vaccine
HK1166955A (en) Formulation
AU2009904829A0 (en) Novel compounds
HK1162317A (en) Novel use
AU2008906136A0 (en) A piece of footwear
AU2010900911A0 (en) Hand flexer - Acu flex
HK1171692A (en) Sustained-release formulation
AU2009902677A0 (en) Novel Therapeutic Uses of SLIRP
HK1163514A (en) Novel forms of bendamustine free base